FdaApplication
NDA 018932
Identifiers
- fda_app_no: NDA018932
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA WOMENS HEALTH INC |
| application_type | NDA |
| approval_date | 1984-11-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REVIA | NALTREXONE HYDROCHLORIDE | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
1 product